Clinical manifestations and main syndromes
Manifestation of the disease can occur at absolutely any age. However, in pediatric practice, the pathology most frequently debuts during puberty, with the overwhelming majority of patients being girls.
The clinical picture of thyrotoxicosis consists of several pronounced syndromes:
- Neurological and psycho-emotional syndrome: patients complain of increased excitability, nervousness, and various sleep disorders. Despite psychomotor agitation, prominent fatigue is characteristic.
- Cardiovascular syndrome: patients report a subjective sensation of strong palpitations. Examination reveals objective tachycardia that persists even at complete rest.
- Autonomic and metabolic syndrome: weight loss is considered a classical sign, although this symptom does not always occur. The skin of patients is typically hot to the touch and hyperemic. A characteristic physical sign is persistent white dermographism.
Ophthalmopathy (ocular symptoms)
Specific eye involvement is the hallmark of diffuse toxic goiter. Ophthalmopathy includes a range of characteristic signs easily detected during visual inspection:
- Wide palpebral fissures combined with infrequent blinking.
- Inability to close the eyes completely, accompanied by fine eyelid tremor upon attempted closure.
- Changes in the appearance of the periorbital area: eyelid pigmentation, enhanced unnatural eye shine, and marked conjunctival hyperemia.
- Impairment of extraocular muscle function: patients exhibit convergence insufficiency, and looking upward fails to produce physiological forehead wrinkles.
Essence of the pathology, pathogenesis, and staging
The disease is based on an autoimmune attack on the thyroid tissue. During the development of the pathology (according to ICD-10 code E06.3, which in this context describes the autoimmune process), specific stages are distinguished:
- Hyperthyroid phase (hashitoxicosis): This condition arises from the inflammatory destruction of thyrocytes (thyroid follicular cells). Pre-synthesized hormone reserves are massively released from the destroyed follicles into the bloodstream. An important clinical feature: unlike true thyrotoxicosis, this destructive phase runs a mild course with minimal clinical manifestations and generally does not require specific antithyroid drug therapy.
- Outcome (hypothyroidism): Over time, as a significant pool of hormone-secreting cells dies off, thyroid function irreversibly declines. This predictably leads to the development of marked thyroid hormone deficiency.
Diagnostic workup
To confirm the diagnosis, a comprehensive approach is used, including laboratory and instrumental methods:
- Instrumental diagnostics: Thyroid ultrasound reveals an increase in organ volume (goiter), diffuse changes in tissue echostructure, and hypervascularization (a significant increase in blood flow, clearly visualized on color Doppler imaging).
- Laboratory diagnostics: Blood tests record a significant elevation in free fractions of thyroid hormones (T3, T4). Meanwhile, thyroid-stimulating hormone (TSH) levels are suppressed and close to zero. The presence of specific antibodies (Abs) indicating the autoimmune nature of the process is also confirmed.
Management tactics and therapy
The management of diffuse toxic goiter requires strict supervision by a pediatric endocrinologist and is based on several key principles:
- Basic therapy: The cornerstone is long-term administration of antithyroid medications such as thiamazole or propylthiouracil.
- Dosing principle: The drug dose is subject to gradual reduction (titration) only after the patient achieves clinical and laboratory euthyroidism (a state in which TSH and free thyroxine levels normalize).
- Symptomatic therapy: Until thyroid function completely normalizes, β-blockers are prescribed to manage pronounced tachycardia.
- Safety monitoring: Antithyroid therapy carries a high risk of hematologic complications, specifically the development of leukopenia and neutropenia. Therefore, regular complete blood count (CBC) monitoring is strictly mandatory. At high drug doses, CBC is checked weekly, and upon transitioning to a maintenance dose, monthly.
- Complications of conservative therapy: Drug-induced hypothyroidism may develop during antithyroid treatment. In such cases, a "block and replace" regimen is applied, requiring the addition of levothyroxine sodium hormone replacement therapy (HRT).
Instrumental monitoring of treatment efficacy is performed using thyroid ultrasound every 3 months to objectively assess changes in organ volume. If the disease takes a continuously relapsing course or uncontrolled growth of the thyroid volume is noted despite conservative therapy, indications for surgical treatment are established.
Class and exam questions
At what age does diffuse toxic goiter most commonly debut in children?
In pediatric practice, the disease can manifest at any age, but the peak incidence definitively occurs in girls during puberty.
Why is frequent complete blood count testing necessary during antithyroid treatment?
This is necessary to monitor treatment safety. Drugs of this group can cause severe hematologic complications such as leukopenia and neutropenia.
What is the essence of the "block and replace" regimen?
This regimen is used when drug-induced hypothyroidism develops during treatment. Antithyroid drugs continue to "block" excessive thyroid function, while the hormone deficiency is "replaced" by adding levothyroxine sodium to the therapy.
How to manage tachycardia at the start of treatment before hormones have normalized?
As symptomatic therapy to control tachycardia until thyroid function normalizes, β-blockers are used.
What else to study on this topic
- Pathogenesis of autoimmune thyroid disease
- Differential diagnosis of hashitoxicosis and true thyrotoxicosis
- "Block and replace" regimen: pharmacokinetics of drugs
- Hematologic complications: pathogenesis of leukopenia and neutropenia
- Surgical treatment: patient preparation and selection of surgical scope
Master the entire topic in the Pediatrics course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Diffuse toxic goiter" and 3,738 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 71 video lessons on the subject
Other topics in the section «Chapter 11. Endocrine Diseases in Children»
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.